Clinical Trial: Helminth (harmless parasitic worm) eggs - National Multiple Sclerosis Society

Skip to navigation Skip to content

Clinical Trial: Helminth (harmless parasitic worm) eggs

Share

Details
Type of MS: RRMS
Treatment mode of action: To affect immune function
Number of Subjects: 20
Medication: Helminth eggs
Location: WI
Contact Information
Andrea Maser, MS
608-265-6544
alm@clinicaltrials.wisc.edu

Funding:

National MS Society

Description

Small clinical trial to determine whether a solution containing tiny helminth eggs can alter the immune attack and reduce relapses.

Share